Unimartpharma Private Limited
About Unimartpharma Private Limited
Data last updated:
Unimartpharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 19 May 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2020PTC339828. Its GSTIN is 27AACCU5915D1ZG (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Pradeep Kumar Singh and Ajay Kumar Sahu.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hedf E 80 7 10 Plot No 387 Patel Nagar Mar Hind Mandal Golibar Colony, Mumbai, Maharashtra, India – 400055.
As per the financials filed for FY 2024, the company reported a revenue of ₹41.33 Lakh. For the same year it recorded a net profit of ₹60,057 (net margin 1.5%) and EBITDA of ₹86,787 (EBITDA margin 2.1%). Revenue has grown at a compounded annual rate (CAGR) of 41% over three years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressHedf E 80 7 10 Plot No 387 Patel Nagar Mar Hind Mandal Golibar Colony, Mumbai, Maharashtra, India – 400055
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity
The main business activity of Unimartpharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Financials of Unimartpharma Private Limited
FY 2025 filings availableUnimartpharma Private Limited reported revenue of ₹41.33 Lakh for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 41% over three years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2020-21 to FY 2022-23in the company report |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | |
| Other Income | •••• | |
| Total Revenue | •••• | |
| Cost of Materials Consumed | •••• | |
| Employee Benefit Expense | •••• | |
| Finance Costs | •••• | |
| Depreciation and Amortisation | •••• | |
| Other Expenses | •••• | |
| Total Expenses | •••• | |
| EBITDA | ₹86,787 | |
| Profit Before Tax | •••• | |
| Tax Expense | •••• | |
| Net Profit (PAT) | ₹60,057 | |
| Balance Sheet | ||
| Share Capital | •••• | |
| Reserves and Surplus | •••• | |
| Net Worth (Total Equity) | •••• | |
| Long-term Borrowings | •••• | |
| Short-term Borrowings | •••• | |
| Trade Payables | •••• | |
| Total Liabilities | •••• | |
| Fixed Assets | •••• | |
| Investments | •••• | |
| Inventories | •••• | |
| Trade Receivables | •••• | |
| Cash and Bank Balance | •••• | |
| Total Assets | •••• | |
Financial Ratios
| Metrics | FY 2023-24 | FY 2020-21 to FY 2022-23in the company report |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 2.1% | |
| Net Profit Margin | 1.5% | |
| Return on Equity (ROE) | •••• | |
| Return on Capital Employed (ROCE) | •••• | |
| Return on Assets (ROA) | •••• | |
| Liquidity and Debt | ||
| Current Ratio | •••• | |
| Quick Ratio | •••• | |
| Debt-to-Equity Ratio | •••• | |
| Interest Coverage Ratio | •••• | |
| Efficiency and Growth | ||
| Asset Turnover | •••• | |
| Receivable Days | •••• | |
| Payable Days | •••• | |
| Inventory Days | •••• | |
| Revenue Growth | •••• | |
| Net Profit Growth | •••• | |
Paid data: the figures shown as dots, and every line for FY 2020-21 to FY 2022-23, are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Unimartpharma are in the company report.
: available in the company report
Board of Directors of Unimartpharma Private Limited
Unimartpharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pradeep Kumar Singh | Director | 19 May 2020 | 6 Years 5 Months | Current |
| Ajay Kumar Sahu | Director | 19 May 2020 | 6 Years 5 Months | Current |
Peer Comparison
Unimartpharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Big Laboratories Private Limited | ₹41.45 Lakh (FY 2021) | •••• | •••• | -48.0% | •••• | New Delhi, Delhi, India |
| Genomics Healthcare Private Limited | ₹41.41 Lakh (FY 2020) | •••• | •••• | 30.0% | •••• | Howrah, West Bengal, India |
| Glary Pharmaceuticals Private Limited | ₹41.39 Lakh (FY 2024) | •••• | •••• | 47.0% | •••• | Lucknow, Uttar Pradesh, India |
| Unimartpharma Private Limited this company | ₹41.33 Lakh (FY 2024) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Sarv Shakti Ayurvedic Pharmaceuticals Private Limited | ₹41.25 Lakh (FY 2016) | •••• | •••• | 13.0% | •••• | Amritsar, Punjab, India |
| Khlorophylls Biotech Private Limited | ₹41.12 Lakh (FY 2024) | •••• | •••• | 13.0% | •••• | Vadodara, Gujarat, India |
| XL Lifeline Private Limited | ₹41.08 Lakh (FY 2024) | •••• | •••• | 58.0% | •••• | Bhubaneswar, Odisha, India |
Peers are the companies nearest to Unimartpharma by revenue, above and below it, in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details
Unimartpharma Private Limited is audited by DEEPAK JHA & CO for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| DEEPAK JHA & CO | Locked | Locked | Locked |
: available in the company report
Ownership and Shareholding
: available in the company report
Charges & Borrowings
Unimartpharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance
Unimartpharma Private Limited has a workforce of 0 employees as of Apr 05, 2024.
: available in the company report
Recent Activity
Unimartpharma Private Limited has 3 board changes on record since 2020: 2 appointments and 1 cessation. The latest: Pankaj Goswami ceased to be Director on 05 Aug 2022.
Credit Ratings, Litigation & Regulatory Alerts
: available in the company report
MSME Payment Delays
: available in the company report
Subsidiaries & Group Companies
: available in the company report
GST Compliance
Unimartpharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCU5915D1ZG | Maharashtra | Active | 03 Aug 2020 |
: available in the company report
MCA Filings & Documents
: available in the company report
Frequently Asked Questions
Unimartpharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 19 May 2020 (6+ years old) and is registered under CIN U51909MH2020PTC339828.
Unimartpharma has 2 current directors:
- Pradeep Kumar Singh - Director
- Ajay Kumar Sahu - Director
The latest financial statements of Unimartpharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Unimartpharma is 27AACCU5915D1ZG, registered in Maharashtra.
The CIN (Corporate Identification Number) of Unimartpharma is U51909MH2020PTC339828. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Unimartpharma was incorporated on 19 May 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Unimartpharma by revenue are Big Laboratories Private Limited, Genomics Healthcare Private Limited, Glary Pharmaceuticals Private Limited, Sarv Shakti Ayurvedic Pharmaceuticals Private Limited, Khlorophylls Biotech Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Pankaj Goswami ceased to be Director on 05 Aug 2022. Ajay Kumar Sahu was appointed as Director on 19 May 2020. Pradeep Kumar Singh was appointed as Director on 19 May 2020.
The registered office of Unimartpharma is at Hedf E 80 7 10 Plot No 387 Patel Nagar Mar Hind Mandal Golibar Colony, Mumbai, Maharashtra, India – 400055.
Unimartpharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Unimartpharma can be reached at its registered office: Hedf E 80 7 10 Plot No 387 Patel Nagar Mar Hind Mandal Golibar Colony, Mumbai, Maharashtra, India – 400055.